Abstract
The mammalian target of rapamycin (mTOR) is extensively involved in multiple myeloma (MM) pathophysiology. In the present study, we reported a novel small molecule SC06 that induced MM cell apoptosis and delayed MM xenograft growth in vivo. Oral administration of SC06 to mice bearing human MM xenografts resulted in significant inhibition of tumor growth at doses that were well tolerated. Mechanistic studies revealed that SC06 selectively inhibited the mTOR signaling pathway but had no effects on other associated kinases, such as AKT, ERK, p38, c-Src and JNK. Further studies showed that SC06-decreased mTOR activation was associated with the downregulation of Raptor, a key component of the mTORC1 complex. SC06 also suppressed the phosphorylation of 4E-BP1 and P70S6K, two typical substrates in the mTORC1 signaling pathway. Notably, expression of Raptor, phosphorylation of mTOR and phosphorylated 4E-BP1 was also decreased in the tumor tissues from SC06-treated mice, which was consistent with the cellular studies. Therefore, given the potency and low toxicity, SC06 could be developed as a potential anti-MM drug candidate by disrupting the mTOR signaling.
References
Sep 21, 2002·Oncogene·Frédéric PeneDidier Bouscary
May 19, 2005·The Journal of Biological Chemistry·Gary G Chiang, Robert T Abraham
Apr 28, 2007·The Biochemical Journal·Laura R PearceDario R Alessi
May 27, 2008·Blood·Xinliang MaoAaron D Schimmer
Dec 22, 2009·The Journal of Biological Chemistry·Ghada A SolimanDiane C Fingar
Dec 8, 2010·Blood·Xinliang MaoAaron D Schimmer
Jan 12, 2011·Molecular Pharmacology·Xinliang MaoAaron D Schimmer
May 24, 2011·Leukemia & Lymphoma·Joseph Gera, Alan Lichtenstein
Mar 1, 2012·International Journal of Cancer. Journal International Du Cancer·Chunhua LingXinliang Mao
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jan 19, 2013·The Journal of Biological Chemistry·Fang YangQimin Zhan
May 4, 2013·Journal of Cell Science·Mathieu Laplante, David M Sabatini
Sep 5, 2013·Current Pharmaceutical Design·Jie LiXinliang Mao
Oct 12, 2013·The Journal of Biological Chemistry·Biyin CaoXinliang Mao
Jan 15, 2014·Molecular Cell·Xian-Yang LiJiang Zhu
Jan 17, 2014·Journal of Hematology & Oncology·Kunkun HanXinliang Mao
Apr 10, 2014·Blood·Yanyan GuSagar Lonial
Jul 19, 2014·Scientific Reports·Biyin CaoXinliang Mao
Sep 26, 2014·Nature Communications·Naval P ShanwareRobert T Abraham
Oct 29, 2014·British Journal of Cancer·A SatheR Nawroth
Oct 30, 2014·Clinical Chemistry·A Gilbert Jelinek, Lorin M Bachmann
Dec 3, 2014·Biochimica Et Biophysica Acta·Kai XuWenyi Wei
Dec 5, 2014·Oncotarget·Jingyu ZhuXinliang Mao
Citations
Mar 24, 2016·Annals of the New York Academy of Sciences·Heather FairfieldMichaela R Reagan
Mar 23, 2017·Journal of Cellular Physiology·Yunqi JiangJinbo Feng
Mar 17, 2017·Anti-cancer Drugs·Hongwu MaoXinliang Mao
Feb 18, 2018·Cancer Science·Xin XuYili Yang
Oct 4, 2017·American Journal of Physiology. Cell Physiology·Nathan HodsonAndrew Philp
Jan 30, 2019·The Cancer Journal·Shaji K Kumar
Mar 22, 2019·The Kaohsiung Journal of Medical Sciences·Ying-Ying XuMing Chen
Mar 22, 2019·The Kaohsiung Journal of Medical Sciences·Jin-Guo YuMin-Hua Shi
May 8, 2019·The Kaohsiung Journal of Medical Sciences·Zi-Ming HuangJia-Li Tao
Feb 23, 2017·Oncotarget·Yuanying ZengXinliang Mao
Oct 6, 2016·Oncotarget·Xin XuXinliang Mao
Sep 23, 2016·Oncotarget·Hanley N Abramson
Mar 28, 2018·Leukemia·Xiaohui ZhangRobert Z Orlowski
Jan 11, 2020·Frontiers in Oncology·Xin XuYili Yang
Dec 7, 2018·Journal of Experimental & Clinical Cancer Research : CR·Ying LiuFang Tian